Dose-response relationship of oral insulin spray in healthy subjects.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetes Care

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.28.6.1353PMID 15920051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhaled insulin

  2006cited by this paper
• Inhaled insulin

  2005cited by this paper
• Exubera inhaled insulin: a review

  2004cited by this paper
• Beneficial Effects of Addition of Oral Spray Insulin (Oralin) on Insulin Secretion and Metabolic Control in Subjects with Type 2 Diabetes Mellitus Suboptimally Controlled on Oral Hypoglycemic Agents

  2004cited by this paper
• Understanding the psychological barriers to effective diabetes therapy

  2004cited by this paper
• Inhaled insulin

  2004cited by this paper
• Alternative routes of insulin delivery

  2003cited by this paper
• Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes.

  2003cited by this paper
• Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery.

  2001cited by this paper
• Inhaled insulin.

  1999cited by this paper
• Injection related anxiety in insulin-treated diabetes.

  1999cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

  1976cited by this paper
• DECLARATION OF HELSINKI.

  1964cited by this paper

• Safety and efficacy of an oral insulin (Capsulin) in patients with early‐stage type 2 diabetes: A dose‐ranging phase 2b study

  2022cites this paper
• Physical methods for enhancing drug absorption from the gastrointestinal tract.

  2021cites this paper
• Protein drug delivery: current dosage form profile and formulation strategies

  2020cites this paper
• 9 Insulin Therapy and Hypoglycemia-Present and Future

  2017cites this paper
• Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis

  2016cites this paper
• New forms of insulin and insulin therapies for the treatment of type 2 diabetes.

  2015cites this paper
• Routes of administration of insulin

  2015cites this paper
• Standardizing the collection and measurement of glucose in exhaled breath and its relationship to blood glucose concentrations

  2014cites this paper
• ORAL INSULIN DELIVERY SYSTEM AND RECENT ADVANCES IN INSULIN DELIVERY

  2014cites this paper
• The RapidMist™ System for Buccal Delivery of Insulin

  2014cites this paper
• Role of Insulin in the Type 2 Diabetes Therapy: Past, Present and Future

  2013cites this paper
• New developments to optimize postprandial glucose control with insulin in patients with diabetes

  2012cites this paper
• Innovative Treatments in Diabetes Type 1

  2012cites this paper
• Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?

  2012cites this paper
• Chitosan and alginate nanoparticles as oral insulin carrier

  2012cites this paper
• Buccal insulin spray for prandial therapy of Type 1 and Type 2 diabetes

  2012cites this paper
• Ultrafast-Acting Insulins: State of the Art

  2012cites this paper
• Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study

  2011cites this paper
• Diabetes - Damages and Treatments

  2011cites this paper
• LONG-AWAITED DREAM OF ORAL INSULIN: WHERE DID WE REACH?

  2011cites this paper
• Insulin Therapy and Hypoglycemia - Present and Future

  2011cites this paper
• Review of clinical trials: update on oral insulin spray formulation

  2010influential citation
• Oral Insulin

  2010cites this paper
• Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.

  2010cites this paper
• Oral insulin – a review of current status

  2010cites this paper
• Insulin Buccal Spray (Oral-Lyn) efficacy in Type 1 Diabetes

  2010cites this paper
• Improvement in glycemic control by gastric electrical stimulation (TANTALUSTM) in overweight subjects with type 2 diabetes

  2009cites this paper
• Oral Insulin and Buccal Insulin: A Critical Reappraisal

  2009cites this paper
• Various non-injectable delivery systems for the treatment of diabetes mellitus.

  2009cites this paper
• Intranasal insulin: PK profile designed specifically for prandial treatment of Type 2 Diabetes

  2008cites this paper
• Delivery of insulin to the buccal mucosa utilizing the RapidMist™ system

  2008cites this paper
• Looking to the Future Focus on DPP-4 Inhibitors for the Treatment of Type 2 Diabetes and Emerging Therapies

  2008cites this paper
• Optimizing the treatment of type 2 diabetes using current and future insulin technologies.

  2008cites this paper
• The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation.

  2007cites this paper
• Comparison of Oral Insulin Spray and Subcutaneous Regular Insulin at Mealtime in Type 1 Diabetes

  2007cites this paper
• Conceptual and design essentials for evaluating mechanisms of change.

  2007cites this paper
• Alternatives routes of insulin delivery.

  2006cites this paper
• Noninjectable methods of insulin administration.

  2006cites this paper
• Advances in insulin delivery systems and devices: Beyond the vial and syringe

  2006cites this paper
• Delivery of parathyroid hormone for the treatment of osteoporosis

  2005cites this paper
• Beneficial Effects of Addition of Oral Spray Insulin (Oralin) on Insulin Secretion and Metabolic Control in Subjects with Type 2 Diabetes Mellitus Suboptimally Controlled on Oral Hypoglycemic Agents

  2004cites this paper
• 30 Upcoming and New Insulin Delivery Systems

  year unknowncites this paper